Skip to content

Effectors of type III secretion systems of Salmonella enterica

Specialized Group:

Francisco Ramos Morales, Joaquin Bernal Bayard

Department of Genetics, Faculty of Biology, University of Seville

Francisco Ramos Morales, Joaquin Bernal Bayard

Group photo. From left to right: Roberto Balbontín, Andrea Bullones Bolaños, Paula Martín Muñoz, Claudia Vallejo Grijalba, Jesús Fernández García, Francisco Ramos Morales, Joaquín Bernal Bayard.

Many Gram-negative pathogenic bacteria possess type III secretion systems (T3SS) associated with virulence. These devices are evolutionarily related to the flagellum, similar to tiny syringes capable of injecting bacterial proteins into the cells of the eukaryotic organism they infect. These proteins, called effectors, often interfere with host cell signal transduction pathways to enable pathogen entry or survival. In many cases, the specific function performed by each effector is unknown. Salmonella enterica serovar Typhimurium is a bacterium capable of infecting numerous animal species. While in mice it produces a life-threatening systemic illness similar to typhoid fever, in humans it causes gastroenteritis. Its virulence largely depends on two T3SSs (T3SS1 and T3SS2) that are encoded in two pathogenicity islands called SPI1 and SPI2, respectively. Between the two they secrete more than 40 effectors (Ramos-Morales, 2012). Salmonella serovar Typhimurium is a bacterium capable of infecting numerous animal species. While in mice it produces a life-threatening systemic illness similar to typhoid fever, in humans it causes gastroenteritis. Its virulence largely depends on two T3SSs (T3SS1 and T3SS2) that are encoded in two pathogenicity islands called SPI1 and SPI2, respectively. Between the two they secrete more than 40 effectors (Ramos-Morales, 2012). Salmonella settles in a vacuole. The establishment of this survival and replication niche depends on effectors of T3SS2, although effectors of the system encoded in SPI1 also participate.

settles in a vacuole. The establishment of this survival and replication niche depends on effectors of T3SS2, although effectors of the system encoded in SPI1 also participate. Salmonella settles in a vacuole. The establishment of this survival and replication niche depends on effectors of T3SS2, although effectors of the system encoded in SPI1 also participate.

SlrP has a domain with several leucine-rich repeat (LRR) motifs that are often involved in protein-protein interactions. In the carboxyl terminal region it has another domain called NEL that is present in other effectors that are part of a new family of proteins with ubiquitin ligase activity. Our group demonstrated that SlrP possesses this activity and that it is capable of interacting with human thioredoxin (Trx), ubiquitylating it and causing a drop in its activity (Bernal-Bayard & Ramos-Morales, 2009). We solved the three-dimensional structure of the complex formed by SlrP and Trx in collaboration with the group of Dr. S. Nessler (Orsay, France). The two proteins form a heterotetramer in which the two SlrP molecules interact with the two Trx molecules, with one via the aforementioned LRR domain, the other via a linker region between the LRR domain and the NEL domain ( Zouhir et al.Ramos-Morales, 2009). We solved the three-dimensional structure of the complex formed by SlrP and Trx in collaboration with the group of Dr. S. Nessler (Orsay, France). The two proteins form a heterotetramer in which the two SlrP molecules interact with the two Trx molecules, with one via the aforementioned LRR domain, the other via a linker region between the LRR domain and the NEL domain ( Zouhir et al., 2010). The effect of both interactions could explain the increase in the rate of cell death that we have observed in HeLa cell cultures expressing SlrP. On the other hand, we also studied the conditions of expression and secretion of SlrP (Cordero-Alba & , 2010). The effect of both interactions could explain the increase in the rate of cell death that we have observed in HeLa cell cultures expressing SlrP. On the other hand, we also studied the conditions of expression and secretion of SlrP (Cordero-Alba

, 2010). The effect of both interactions could explain the increase in the rate of cell death that we have observed in HeLa cell cultures expressing SlrP. On the other hand, we also studied the conditions of expression and secretion of SlrP (Cordero-Alba star , 2010). The effect of both interactions could explain the increase in the rate of cell death that we have observed in HeLa cell cultures expressing SlrP. On the other hand, we also studied the conditions of expression and secretion of SlrP (Cordero-Alba & Ramos-Morales, 2013). In addition, transcriptomic analysis was performed on HeLa cells stably transfected with the SteA effector gene. The expression of SteA in these epithelial cells, through the modification of different signal transduction pathways, resulted in an alteration of cell morphology and a decrease in the rate of spontaneous cell death, intercellular junctions and migration speed. cell phone (Cardinal-Muñoz et al.Ramos-Morales, 2013). In addition, transcriptomic analysis was performed on HeLa cells stably transfected with the SteA effector gene. The expression of SteA in these epithelial cells, through the modification of different signal transduction pathways, resulted in an alteration of cell morphology and a decrease in the rate of spontaneous cell death, intercellular junctions and migration speed. cell phone (Cardinal-Muñoz

Ramos-Morales, 2013). In addition, transcriptomic analysis was performed on HeLa cells stably transfected with the SteA effector gene. The expression of SteA in these epithelial cells, through the modification of different signal transduction pathways, resulted in an alteration of cell morphology and a decrease in the rate of spontaneous cell death, intercellular junctions and migration speed. cell phone (Cardinal-Muñoz Salmonella Ramos-Morales, 2013). In addition, transcriptomic analysis was performed on HeLa cells stably transfected with the SteA effector gene. The expression of SteA in these epithelial cells, through the modification of different signal transduction pathways, resulted in an alteration of cell morphology and a decrease in the rate of spontaneous cell death, intercellular junctions and migration speed. cell phone (Cardinal-Muñoz srfJ is positively regulated by PhoP through the SsrA/SsrB two-component system and negatively by IolR, the repressor of genes involved in the use of myo-inositol as a carbon source (Cordero-Alba et al.is positively regulated by PhoP through the SsrA/SsrB two-component system and negatively by IolR, the repressor of genes involved in the use of myo-inositol as a carbon source (Cordero-Alba srfJ is positively regulated by PhoP through the SsrA/SsrB two-component system and negatively by IolR, the repressor of genes involved in the use of myo-inositol as a carbon source (Cordero-Alba Salmonella is positively regulated by PhoP through the SsrA/SsrB two-component system and negatively by IolR, the repressor of genes involved in the use of myo-inositol as a carbon source (Cordero-Alba Salmonella is positively regulated by PhoP through the SsrA/SsrB two-component system and negatively by IolR, the repressor of genes involved in the use of myo-inositol as a carbon source (Cordero-Alba et al.is positively regulated by PhoP through the SsrA/SsrB two-component system and negatively by IolR, the repressor of genes involved in the use of myo-inositol as a carbon source (Cordero-Alba

SseK1 is part of a family of effectors that catalyze the transfer of N-acetylglucosamine to arginine residues of certain host proteins. Our group has shown that SseK1 has a role in the virulence of Salmonella SseK1 is part of a family of effectors that catalyze the transfer of N-acetylglucosamine to arginine residues of certain host proteins. Our group has shown that SseK1 has a role in the virulence of sseK1 SseK1 is part of a family of effectors that catalyze the transfer of N-acetylglucosamine to arginine residues of certain host proteins. Our group has shown that SseK1 has a role in the virulence of et al.SseK1 is part of a family of effectors that catalyze the transfer of N-acetylglucosamine to arginine residues of certain host proteins. Our group has shown that SseK1 has a role in the virulence of

SseK1 is part of a family of effectors that catalyze the transfer of N-acetylglucosamine to arginine residues of certain host proteins. Our group has shown that SseK1 has a role in the virulence of Pseudomonas aeruginosaSseK1 is part of a family of effectors that catalyze the transfer of N-acetylglucosamine to arginine residues of certain host proteins. Our group has shown that SseK1 has a role in the virulence of S. enterica serovar Typhimurium in which we have expressed the PcrV antigen from P. aeruginosa in fusion with the SseJ effector of Salmonella. Mice immunized with this vaccine that were later infected with P. aeruginosa . Mice immunized with this vaccine that were later infected with et al.. Mice immunized with this vaccine that were later infected with

. Mice immunized with this vaccine that were later infected with

Representative bibliography

. Mice immunized with this vaccine that were later infected with & . Mice immunized with this vaccine that were later infected with . Mice immunized with this vaccine that were later infected with Salmonella . Mice immunized with this vaccine that were later infected with Front Microbiol 8. Mice immunized with this vaccine that were later infected with

. Mice immunized with this vaccine that were later infected with & . Mice immunized with this vaccine that were later infected with (2019). A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa. mSphere 4(2019). A Live

(2019). A Live & . Mice immunized with this vaccine that were later infected with (2019). A Live Salmonella enterica. Front Microbiol 6(2019). A Live

(2019). A Live & . Mice immunized with this vaccine that were later infected with (2019). A Live Salmonella (2019). A Live J Biol Chem (2019). A Live(2019). A Live

(2019). A Live & . Mice immunized with this vaccine that were later infected with (2019). A Live Salmonella (2019). A Live Salmonella (2019). A Live J Biol Chem (2019). A Live(2019). A Live

(2019). A Live & . Mice immunized with this vaccine that were later infected with (2019). A Live Salmonella enterica. J Bacteriol (2009). Relevant role of fibronectin-binding proteins in(2019). A Live

(2019). A Live & . Mice immunized with this vaccine that were later infected with (2019). A Live Salmonella (2019). A Live Biochem Biophys Res Commun (2019). A Live(2019). A Live

(2019). A Live & . Mice immunized with this vaccine that were later infected with (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in Salmonella enterica (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in J Bacteriol (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in(2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in

(2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in & . Mice immunized with this vaccine that were later infected with (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in Salmonella (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in J Bacteriol (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in(2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in

. Mice immunized with this vaccine that were later infected with (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in Salmonella enterica (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in ISRN Cell Biol 2012(2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in

(2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in & (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in Biochem J (2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in(2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in

Play Video

Privacy Policy

This website is owned by the SPANISH SOCIETY OF MICROBIOLOGY, whose identification data are the following:

  • Center for Biological Research (CIB-CSIC)
  • c / Ramiro de Maeztu, 9 28040 Madrid.
  • Phone. 91 561 33 81 - Fax. 91 561 32 99
  • National Registry of Associations with the national number 579
  • CIF: G28648871

1. INFORMATION AND CONSENT.

By accepting this Privacy Policy, the User is informed and gives their free, informed, specific and unequivocal consent so that the personal data provided through this website (hereinafter, the "Website") are processed by SEM.

2. OBLIGATORY TO PROVIDE THE DATA.

The data requested in the web forms are generally mandatory (unless otherwise specified in the required field) to fulfill the established purposes. Therefore, if they are not provided or are not provided correctly, they will not be able to be attended to, without prejudice to the fact that you can freely view the content of the Website.

3. FOR WHAT PURPOSE WILL THE USER'S PERSONAL DATA BE PROCESSED AND FOR HOW LONG?

The personal data provided through the Website will be processed by SEM in accordance with the following purposes:

  • Manage and process the registration requests of new members, from the "new members" forms, as well as manage the fees and derived charges.
  • Periodically send members, including by electronic means, information, events or news that may be of interest to them, if the future member gives their consent by checking the corresponding check box, or, where appropriate, opposes or revokes their consent.

4. WHAT USER DATA WILL BE PROCESSED?

SEM will process the following categories of User data:

  • Identification data: name, surname and ID.
  • Contact information: postal address, email address and telephone.
  • Professional data: workplace and professional contact details.
  • Academic data: degree and specialization.
  • Billing information.

5. WHAT IS THE LEGITIMATION OF THE PROCESSING OF USER DATA?

The treatment of the User's data by the SEM is based on the consent that is requested and that you can withdraw at any time. However, in case of withdrawing your consent, this will not affect the legality of the treatments carried out previously.
The consents obtained for the aforementioned purposes are independent so that the User may revoke only one of them, not affecting the others.

6. TO WHICH RECIPIENTS WILL THE USER DATA BE COMMUNICATED?

The data of the partners may be communicated to the following companies in the cases indicated:

• To the corresponding banking entities in order to manage the collection of direct debit bills.

The User's data will not be communicated to any other entity, except legal obligation.

7. RESPONSIBILITY OF THE USER.

The User and the Candidate for membership:
- Guarantees that you are over 18 years of age and that the data you provide to the SEM is true, accurate, complete and updated. For these purposes, the User is responsible for the veracity of all the data that he communicates and will keep the information provided suitably updated, in such a way that it responds to his real situation.
- You will be responsible for the false or inaccurate information that you provide through the Website and for the direct or indirect damages that this causes to the SEM or to third parties.

8. COMMUNICATIONS.

One of the purposes for which the SEM processes the personal data provided by Users is to send them electronic communications with information related to congresses and other events, grant programs, scientific dissemination, awards or relevant news for the recipients.
In the event that the recipient wishes to stop receiving informative communications from the SEM, they can request the cancellation of the service by sending an email to secretaria.sem@semicrobiologia.com or by clicking on the "unsubscribe" link included in the communications.

9. EXERCISE OF RIGHTS.

The User can send a letter at any time and free of charge to the SEM, Centro de Investigaciones Biológicas (CIB-CSIC) - c / Ramiro de Maeztu, 9 28040 Madrid, attaching a photocopy of their identity document, to request their rights of access, rectification, deletion, opposition, limitation, portability of your data.
You can also complain to the Spanish Agency for Data Protection, through the following address: Spanish Agency for Data Protection, C / Jorge Juan, 6, 28001-Madrid, when the interested party considers that the SEM has violated the rights that They are recognized by the applicable regulations on data protection.

10. SECURITY MEASURES.

The SEM will treat the data of Users, Candidates and Partners at all times in an absolutely confidential manner and keeping the mandatory duty of secrecy regarding them, in accordance with the provisions of the applicable regulations, adopting technical measures and measures for this purpose. necessary organizational measures that guarantee the security of your data and prevent its alteration, loss, treatment or unauthorized access, taking into account the state of technology, the nature of the stored data and the risks to which they are exposed.

(2014). Patterns of expression and translocation of the ubiquitin ligase SlrP in Salmonella enterica